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12 T H E  C A N C E R  C E N T E R
STATISTICAL REPORT
2    LEHIGH VALLEY HEALTH NETWORK
W E L C O M E
Welcome to Lehigh Valley Health 
Network Cancer Program’s 2012 
Statistical Report, featuring data on 
cancer cases we treated in 2011.
In September 2011, Lehigh Valley Health 
Network Cancer Program earned three-year 
accreditation, with commendation, from the 
American College of Surgeons Commission on 
Cancer (ACoS/CoC). 
Our Cancer Program’s Breast Health Services 
received reaccreditation by the National 
Accreditation Program for Breast Centers 
(NAPBC) in April 2012 and is designated by the 
American College of Radiology (ACR/ASTRO) 
as Breast Center of Excellence. 
In February 2012, our Department of Radiation 
Oncology received three-year full accreditation 
from the American College of Radiology/
American Society for Therapeutic Radiation 
Oncology (ACR). 
Our Cancer Program is a proud participant 
in the National Cancer Institute’s (NCI) 
Community Cancer Centers 
Program (NCCCP). Only 21 cancer 
institutions nationwide hold this 
distinction as of July 2012. 
Lehigh Valley Health Network is 
an affiliate of Moffitt Cancer Center, Tampa 
Fla., and The Wistar Institute of Anatomy and 
Biology, Philadelphia Pa. 
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2011 LEHIGH VALLEY HEALTH NETWORK 
CANCER CASE INFORMATION
Lehigh Valley Hospital–Cedar Crest and Lehigh Valley Hospital–Muhlenberg, collectively Lehigh Valley 
Health Network (LVHN), were involved in the diagnosis and/or treatment of more than 3,100 cancer pa-
tients in 2011. Ninety-three percent (2,918) of those cases were considered analytic cases directly diagnosed 
and/or treated at the health network. Of these, about 30 percent (853) were diagnosed at another medical 
facility and referred to LVHN for part or all of their cancer treatment. 
The top five most prevalent cancers treated at the health network remain consistent across the past 10 years.
SOME COMMONLY USED TERMINOLOGY
American Joint Committee on Cancer (AJCC) Staging: A classification system used for describing the extent of 
disease progression based on the evaluation of the tumor size/invasiveness (T), nodal status (N) and metastasis 
(M) at the time of diagnosis. AJCC stage is important in considering treatment plans.
Analytic Cancer Case: Analytic cases are cases for which the facility provided the initial diagnosis of cancer 
and/or for which the facility contributed to all or part of the first course of treatment.
Collaborative Staging: Cancer stage historically has been collected using three different staging systems:
Collaborative Stage is a unified data collection system designed to provide a common data set to meet the 
needs of all three staging systems and provide a comprehensive system to improve data quality by standard-
izing rules for timing, clinical and pathological assessments, and compatibility across all of the systems for all 
cancer sites.
National Cancer Database: The National Cancer Database (NCDB) is a joint project of the American Cancer 
Society and the Commission on Cancer. This database collects information on cancer cases diagnosed and/
or treated at hospitals throughout the country. This non-patient identified information is used to present 
scientifically reviewed descriptions of patient diagnosis, treatment and outcomes. The most recent data from 
NCDB is on cases newly diagnosed in 2010. 
YEAR MOST TREATED 2 3 4 5
2011 Breast Lung Prostate Colon/Rectum Bladder
2010 Lung Breast Colon/Rectum Prostate Corpus Uteri
2009 Breast Lung Prostate Colon/Rectum Skin
2008 Breast Lung Colon/Rectum Prostate Urinary Bladder
2007 Breast Lung Colon/Rectum Prostate Skin
2006 Breast Lung Prostate Colon/Rectum Urinary Bladder
2005 Breast Lung Colon/Rectum Prostate Thyroid
2004 Breast Lung Prostate Colon/Rectum Skin
2003 Breast Lung Colon/Rectum Prostate Urinary Bladder
2002 Breast Prostate Lung Colon/Rectum Urinary Bladder





























TOTAL ANNUAL ANALYTIC CASES 
YEARS 2000–2011
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COUNTY OF 
 RESIDENCE 2007 2008 2009 2010 2011
Adams 0 1 0 0 0
Beaver 0 0 0 0 2
Berks 185 153 170 171 166
Bradford 2 1 1 0 0
Bucks 49 30 52 59 41
Cambria 0 0 0 0 0
Carbon 141 129 169 183 168
Centre 0 3 2 1 0
Chester 7 2 3 3 3
Clinton 0 11 0 0 0
Clearfield 1 0 0 1 0
Columbia 5 4 4 3 6
Cumberland 1 0 0 0 1
Dauphin 2 3 1 0 0
Delaware 0 5 0 3 0
Elk 1 0 0 0 0
Fayette 0 0 1 0 0
Franklin 0 0 0 2 0
Lackawanna 34 36 36 39 47
Lancaster 2 1 0 1 1
Lebanon 0 1 1 2 2
Lehigh 1,316 1,357 1,301 1,328 1,393
Luzerne 66 80 83 80 73
Lycoming 2 1 1 3 2
Monroe 86 90 107 93 127
Montgomery 53 62 67 81 62
Northampton 533 578 599 643 619
Northumberland 2 1 0 1 1
Perry 1 0 0 0 0
Philadelphia 1 1 0 3 0
Pike 8 4 12 22 9
Potter 1 1 0 0 1
Schuylkill 77 76 117 98 120
Sullivan 0 0 1 0 0
Susquehanna 2 3 3 3 1
Tioga 0 0 0 0 1
Warren 0 0 0 0 1
Wayne 5 8 5 6 6
Wyoming 2 9 3 3 1
York 1 0 1 2 3
Out of State 46 55 69 53 61
TOTALS 2,632 2,706 2,809 2,887 2,918
Data Source: LVHN Tumor Registry. All cases diagnosed and/or treated through Lehigh 
Valley Health Network’s Cancer Program.
During the past five years, 67-71 
percent of cancer patients diagnosed 
and/or treated by Lehigh Valley Health 
Network resided in either Lehigh or 
Northampton counties. Other counties 
making up an average 20 percent of 
the health network’s cancer patients 
included, in decreasing order: Carbon, 
Berks, Monroe and Schuylkill.
INCIDENCE BY COUNTY
* Diagnosed and all first course of 
treatment received elsewhere prior 
to coming to Lehigh Valley Health 
Network.
 YEAR NUMBER  
 2007 208 
 2008 156 
 2009 165 
 2010 227 
 2011 234
NON-ANALTYIC CASES*
6    LEHIGH VALLEY HEALTH NETWORK
2011 ANALYTIC* CASES BY PRIMARY BODY SITE
PRIMARY SITE MALE (N) FEMALE (N) TOTAL Percent
Head and Neck
LIP 1 0 1 1.3%
BASE OF TONGUE 3 4 7 9.3%
OTHER PARTS OF TONGUE 6 3 9 12.0%
GUM 0 1 1 1.3%
FLOOR OF MOUTH 2 2 4 5.3%
OTHER/UNSPECIFIED PARTS OF MOUTH 2 1 3 4.0%
PAROTID GLAND 2 3 5 6.7%
OTHER SALIVARY GLANDS 2 1 3 4.0%
TONSIL 12 2 14 18.7%
NASOPHARYNX 1 0 1 1.3%
PYRIFORM SINUS 1 0 1 1.3%
HYPOPHARYNX 1 0 1 1.3%
NASAL CAVITY and MIDDLE EAR 0 3 3 4.0%
ACCESSORY SINUSES 2 0 2 2.7%
LARYNX 15 5 20 26.7%
Subtotal 50 25 75 100.0%
Digestive Organs
ESOPHAGUS 21 7 28 5.8%
STOMACH 38 8 46 9.5%
SMALL INTESTINE 6 1 7 1.4%
COLON and RECTUM 137 135 272 56.0%
ANUS and ANAL CANAL 2 9 11 2.3%
LIVER and BILE DUCTS 25 11 36 7.4%
GALLBLADDER 1 2 3 0.6%
OTHER BILIARY TRACT 8 4 12 2.5%
PANCREAS 39 30 69 14.2%
OTHER DIGESTIVE ORGANS 2 0 2 0.4%
Subtotal 279 207 486 100.0%
Respiratory Organs
TRACHEA 0 1 1 0.3%
BRONCHUS and LUNG 200 164 364 97.8%
THYMUS 0 2 2 0.5%
HEART MEDIASTINUM PLEURA 3 2 5 1.3%
Subtotal 203 169 372 100.0%
Breast
BREAST 0 427 427 100.0%
Subtotal 0 427 427 100.0%
Female Genital Organs
VULVA 0 27 27 10.0%
VAGINA 0 3 3 1.1%
CERVIX UTERI 0 27 27 10.0%
CORPUS UTERI 0 147 147 54.6%
UTERUS NOS 0 2 2 0.7%
OVARY 0 60 60 22.3%
OTHER FEMALE GENITAL ORGANS 0 3 3 1.1%
Subtotal 0 269 269 100.0%
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*Analytic cases are cases diagnosed and/or treated through Lehigh Vallley Health Network Cancer Program. 
PRIMARY SITE MALE (N) FEMALE (N) TOTAL Percent
Male Genital Organs
PENIS 5 0 5 1.7%
PROSTATE GLAND 275 0 275 94.5%
TESTIS 10 0 10 3.4%
OTHER and UNSPECIFIED MALE GENITAL ORGANS 1 0 1 0.3%
Subtotal 291 0 291 100.0%
Urinary Tract Organs
KIDNEY 76 35 111 37.8%
KIDNEY, RENAL PELVIS 7 3 10 3.4%
URETER 3 2 5 1.7%
URINARY BLADDER 128 36 164 55.8%
OTHER and UNSPECIFIED URINARY ORGANS 3 1 4 1.4%
Subtotal 217 77 294 100.0%
Opthalmic Sites
ORBIT, NOS and OVERLAPPING LESION 0 1 1 100.0%
Subtotal 0 1 1 100.0%
Central Nervous System
MENINGES 23 51 74 51.4%
BRAIN 36 22 58 40.3%
OTHER NERVOUS SYSTEM 8 4 12 8.3%
Subtotal 67 77 144 100.0%
Endocrine Glands
THYROID GLAND 16 50 66 66.0%
ADRENAL GLAND 1 4 5 5.0%
OTHER ENDOCRINE GLANDS 14 15 29 29.0%
Subtotal 31 69 100 100.0%
Skin
SKIN 69 53 122 100.0%
Subtotal 69 53 122 100.0%
Musculoskelatal Sites
BONES, JOINTS and ARTICULAR CARTILAGE 1 1 2 7.7%
BONES, JOINTS and OTHER UNSPECIFIED SITES 4 2 6 23.1%
CONNECTIVE SUBCUTANEOUS OTHER SOFT TISSUE 11 7 18 69.2%
Subtotal 16 10 26 100.0%
Other Sites
HEMATOPOIETIC and RETICULOENDOTHELIAL SYSTEMS 71 72 143 46.0%
OTHER ILL DEFINED SITES  
(includes RETROPERITONEUM and PERITONEUM) 4 7 11 3.5%
LYMPH NODES 65 48 113 36.3%
UNK PRIMARY 19 25 44 14.1%
Subtotal 159 152 311 100.0%
TOTAL 1,382 1,536 2,918 100.0%
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Breast cancer has been the most frequently 
treated cancer at Lehigh Valley Health Network 
for the past 10 years, accounting for 14.6 
percent of 2011 newly diagnosed cases. In 
2011, at the health network, 49 percent of 
new breast cancer cases occurred in women 
between ages 50–69, and 24 percent of cases 
occurred in women under the age of 50. These 
findings are in line with nationally reported 
age at diagnosis. Treatment options at Lehigh 
Valley Health Network are in keeping with the 
National Comprehensive Cancer Network (NCCN) 
guidelines and also reflect those reported by the 
NCDB. More cancers were identified at an early 
stage than nationally reported through the 2010 
National Cancer Database. Twenty-five percent 
of the health network’s breast cancer cases were 
diagnosed at stage 0 compared with only 20.6 
percent of nationally reported cases according to 
the NCDB. Through our Breast Health Services 
(BHS) mammography screening, our health 
network has continuously set the pace for 









BREAST CANCER BY AGE AT DIAGNOSIS     























89 90 + TOTAL
(N) 2 15 86 101 108 75 39 1 427
























Surgery + Radiation + 
Chemotherapy
Surgery + Radiation + 
Hormone
Surgery + Hormone
Surgery + Radiation + 
Chemotherapy + Hormone
Surgery + Chemotherapy + 
Hormone
Other Specified Therapy
No 1st Course Rx
LVHN 2011 NCDB 2010
COMPARISON OF AJCC COLLABORATIVE STAGE FIRST COURSE OF TREATMENT

















































LVHN 2011 NCDB 2010
COMPARISON OF AJCC COLLABORATIVE STAGE AT DIAGNOSIS
2011 LEHIGH VALLEY HEALTH NETWORK CANCER CENTER
BREAST CANCER TREATMENT BY STAGE AT DIAGNOSIS (N=427)














Surgery Only 36% 13% 10% 7% 4% 22% 17.6%
Surgery + Radiation Therapy 32% 19% 5% 0% 0% 11% 16.2%
Surgery + Chemotherapy 0% 5% 3% 7% 4% 11% 3.7%
Surgery + Radiation Therapy + 
 Chemotherapy 0% 5% 14% 7% 0% 0% 5.4%
Surgery + Radiation Therapy +  
Hormone Therapy 16% 33% 22% 9% 0% 11% 21.8%
Surgery + Hormone Therapy 9% 13% 8% 9% 0% 11% 9.8%
Surgery + Radiation Therapy + 
 Chemotherapy + Hormone Therapy 0% 3% 20% 42% 4% 0% 9.6%
Surgery + Chemotherapy +  
Hormone Therapy 1% 1% 7% 7% 9% 0% 3.3%
Other Specified Therapy 0% 3% 10% 9% 65% 11% 8.0%
No 1st Course Rx 6% 4% 1% 2% 13% 22% 4.7%
Total Number of Cases 107 158 87 43 23 9 427
FOR MORE INFORMATION GO TO LVHN.org/cancer
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Lung cancer has been the second most frequently 
treated cancer at Lehigh Valley Health Network for 
the past nine years. In 2011, lung cancer accounted 
for 12.5 percent of our health network’s analytic 
cases. More than half (55 percent) of these cases 
were male. About 82 percent of newly diagnosed 
patients were at or above 60 years of age, 
compared to 79 percent reported by the NCDB. 
Twenty-five percent of lung cancers at the health 
network were stage 1, and 6 percent stage 2, all of 
which were candidates for primary surgical 
resection. In stage 3 disease, 34 percent of 
patients underwent combined modality chemo-
therapy/radiation as the initial course of treatment. 
In stage 4 disease, 46 percent of patients received 
either palliative chemotherapy (23 percent) or 
combined chemotherapy/radiation therapy (23 
percent). Lehigh Valley Health Network reported 
fewer stage 4 cases (38 percent) than reported by 
NCDB (44 percent). Treatment pat terns are in 
keeping with the National Comprehensive Cancer 
Network (NCCN) guidelines and reflect those 
reported in the 2010 NCDB.















89 90 + TOTAL
(N) 2 11 53 115 112 64 7 364
INCIDENCE OF LUNG CANCER BY AGE AT DIAGNOSIS    
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Surgery + Radiation + 
Chemotherapy
Other Specified Therapy
No 1st Course Rx
COMPARISON OF FIRST COURSE OF TREATMENT

















































LVHN 2011 NCDB 2010
COMPARISON OF AJCC COLLABORATIVE STAGE AT DIAGNOSIS
2011 LEHIGH VALLEY HEALTH NETWORK CANCER CENTER



















Surgery Only 100% 68% 35% 8% 2% 0% 78% 17% 24.7%
Radiation Only 0% 13% 0% 8% 17% 0% 0% 17% 11.8%
Surgery and 
 Chemotherapy 0% 5% 17% 6% 1% 0% 0% 0% 4.7%
Radiation and 
 Chemotherapy 0% 3% 13% 34% 23% 0% 0% 0% 19.0%
Chemotherapy Only 0% 1% 4% 3% 23% 0% 0% 17% 10.2%
Surgery, Radiation and 
Chemotherapy 0% 1% 9% 12% 1% 0% 0% 0% 4.1%
Other Specified Therapy 0% 1% 0% 4% 7% 0% 0% 0% 3.8%
No 1st Course Rx 0% 8% 22% 25% 27% 100% 22% 50% 21.7%
Total Number  
of Cases 1 93 23 93 137 2 9 6 364
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Prostate cancer was the third most frequently 
treated cancer at Lehigh Valley Health Network 
in 2011. The 275 analytic cases diagnosed in 
2011 accounted for 9.4 percent of all analytic 
cancer cases at the health network. Seventy-
four percent (74 percent) of newly diagnosed 
patients at the health network were between 
the ages of 50 to 69 in comparison to the 2010 
National Cancer Database (NCDB) reported rate 
of 68 percent. Percent of cases newly diagnosed 
at stage 2 (76 percent) were similar for the 
health network as NCDB cases diagnosed 
at stages 1 and 2 (80 percent) combined. To 
increase community awareness, the health 
network implemented a series of prostate cancer 
screenings and education events offered free to 
the public in 2012. Treatment options at LVHN 
are in keeping with National Comprehensive 
Cancer Network (NCCN) guidelines and reflect 
those reported in the most recent 2010 NCDB. 
Most men continue to choose surgical definitive 
treatment at both the health network (60 percent) 
and nationwide (54 percent). 
PROSTATE  
CANCER
INCIDENCE OF PROSTATE CANCER BY AGE AT 
DIAGNOSIS LVHN 2011
Age 
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PROSTATE CANCER BY AGE AT DIAGNOSIS  
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2011 LEHIGH VALLEY HEALTH NETWORK CANCER CENTER














Surgery Only 0% 60% 76% 9% 0% 89% 58.9%
Radiation Only 0% 14% 0% 0% 0% 0% 10.9%
Radiation + Hormone Therapy 0% 17% 0% 26% 0% 0% 14.9%
Hormone Therapy Only 0% 0% 3% 26% 0% 0% 2.5%
Other Specified Therapy 0% 3% 21% 30% 0% 0% 3.6%
No 1st Course Rx 0% 6% 0% 9% 0% 11% 5.5%
Total Number of Cases 0 209 34 23 0 9 275














































LVHN 2011 NCDB 2010
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Colorectal cancer was the fourth most frequently 
treated cancer (N=272) at Lehigh Valley Health 
Network in 2011 accounting for 9.3 percent of 
all newly diagnosed cases. From 2004 through 
2008 (most recent Centers for Disease Control 
and Prevention Cancer Statistics available), 
colorectal cancer has consistently ranked fourth 
across the United States. The incidence of 
colorectal cancer is evenly distributed between 
men (50.4 percent) and women (49.6 percent). 
More than 60 percent of all newly diagnosed 
patients, both at the health network and 
nationwide, are diagnosed at stage 2 or greater. 
To increase community awareness, the health 
network implemented a series of colorectal 
screening and education sessions in 2012. 
COLON CANCER
Nearly 80 percent of colon cancers diagnosed 
at the health network were 60 years of age and 
older compared to 73 percent by the National 
Cancer Database (NCDB). In 2011, the health 
network was more likely to see cases diagnosed 
at a later stage, 49 percent, than those reported 
by NCDB, 43 percent. Surgical resection in 
combination with or without chemotherapy is the 
most common treatment approach for all stages 
of colon cancer at the health network (83.3 
percent) comparable to 2010 NCDB reported 
cases (82.7 percent).








COLON CANCER BY AGE AT DIAGNOSIS  





















89 90 + TOTAL
(N) 3 11 29 58 47 45 17 210
2011 LEHIGH VALLEY HEALTH NETWORK CANCER CENTER
















Surgery Only 100% 100% 76% 47% 19% 0% 0% 58.6%
Surgery + Chemotherapy 0% 0% 17% 44% 30% 100% 0% 24.8%
Surgery + Radiation + 
 Chemotherapy 0% 0% 5% 9% 0% 0% 0% 4.3%
Other Specified Therapy 0% 0% 0% 0% 24% 0% 17% 4.8%
No 1st Course Rx 0% 0% 2% 0% 27% 0% 83% 7.6%
Total Number of Cases 8 32 59 66 37 2 6 210
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Rectal cancer patients were more likely to be 
diagnosed at an earlier stage than colon cancer 
patients.  Eighty-three percent (83 percent) of 
the health network patients were diagnosed 
at age 50 and older compared with 85 percent 
of reported NCDB patients in this age range.  
Treatment options for rectal cancer were 
more variable than those selected for colon 
cancer.  Definitive surgery alone was more 
often recommended for stage 0 and stage 1 
rectal cancer at the health network (77 percent) 
compared with 62 percent of NCDB reported 
cases. However, surgery and radiation plus 
systemic therapies were recommended at the 
health network (32.3 percent) compared to 
NCDB (36.3 percent) for stage 1 through  
stage 3 cases.  
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RECTUM CANCER BY AGE AT DIAGNOSIS   
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2011 LEHIGH VALLEY HEALTH NETWORK CANCER CENTER
















Surgery Only 100% 71% 21% 22% 11% 100% 33% 42%
Surgery + Chemotherapy 0% 0% 0% 0% 0% 0% 0% 0%
Radiation + Chemotherapy 0% 0% 26% 0% 22% 0% 0% 11.3%
Surgery + Radiation + 
Chemotherapy 0% 29% 42% 67% 22% 0% 0% 32.3%
Other Specified Therapy 0% 0% 5% 11% 22% 0% 0% 6.5%
No 1st Course Rx 0% 0% 5% 0% 22% 0% 67% 8.1%
Total Number of Cases 4 14 19 9 9 4 3 62
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URINARY 
 BLADDER CANCER
Bladder cancer emerged as the fifth most 
frequently treated cancer at Lehigh Valley Hospital 
Network in 2011, accounting for 5.6 percent of all 
newly diagnosed analytic cases. The majority of 
bladder cancer cases (84 percent) were diagnosed 
in patients age 60 or older. There were no cases 
diagnosed in patients younger than 30 years at the 
health network compared to 0.2 percent of NCDB 
2010 reported cases. The health network was 
more likely to diagnose cases at an early stage (63 
percent diagnosed at stage 0) than cases reported 
to the NCDB (49 percent diagnosed at stage 0). 
Surgery alone was the most common treatment 
offered for all stages of urinary bladder cancer at 
the health network (63.43 percent) comparable to 
2010 NCDB (62.2 percent) reported cases. NCDB 
reported 16.5 percent of cases treated with surgery 
and chemotherapy as compared to the health 
network (22.6 percent) of cases. Treatment options 
are in keeping with the National Comprehensive 
Cancer Network (NCCN) guidelines and reflect 






URINARY BLADDER CANCER BY AGE AT DIAGNOSIS  





INCIDENCE OF URINARY BLADDER CANCER  
















89 90 + TOTAL
(N) 0 2 7 17 34 56 41 7 164
COMPARISON OF FIRST COURSE OF TREATMENT
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0-29 (0%)
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2011 LEHIGH VALLEY HEALTH NETWORK CANCER CENTER
















Surgery Only 67% 71% 50% 50% 42% 0% 67% 63.4%
Surgery + Chemotherapy 21% 21% 28% 25% 25% 0% 33% 22.6%
Surgery + BRM 8% 4% 0% 0% 0% 0% 0% 5.5%
Other Specified Therapy 1% 4% 17% 25% 25% 0% 0% 4.3%
No 1st Course Rx 3% 0% 6% 0% 8% 0% 0% 3%
Total Number of Cases 103 24 18 4 12 0 3 164
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SERVICES AT LEHIGH VALLEY 
HEALTH NETWORK
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THE TUMOR REGISTRY DEPARTMENT 
The Tumor Registry Department is an integral part of 
Lehigh Valley Health Network’s Cancer Center. 
Through systematic collection, management, analysis 
and follow-up of data on all patients with a diagnosis of 
malignancy or reportable benign disease, the tumor 
registry plays an important part in efforts to improve 
cancer care. 
SERVICES AT LEHIGH 
 VALLEY HEALTH NETWORK
The Cancer Center at Lehigh Valley Health Network 
provides a variety of support and educational programs 
for patients, family members and the general public. Most 
of these services and programs are offered free of charge. 
CANCER SURVIVOR EVENTS
Two breast cancer survivor events were held in fiscal 
year 2012. These workshops are designed specifically for 
breast cancer survivors who have completed their 
treatment. These full-day events include presentations 
by one of our physicians, a nurse practitioner, sex 
 therapist and dietitian. This year, 34 women attended 
the events. In June 2012, we held our 10th Annual 
Cancer Survivor Celebration. More than 130 people 
attended. This event included dinner, a musical presen-
tation by Richard Boulay, MD, and an inspirational and 
humorous presentation by comedienne Brenda Elsagher, 
a 20-year colon cancer survivor 
COUNSELING SERVICES
Counseling services are provided by a team of licensed 
clinical social workers, a psychologist and a psychiatrist. 
Phone consultations are provided on an individual basis 
to newly diagnosed patients seeking information. 
Short-term individual and family therapy, as well as 
individual counseling is available. The health network’s 
Cancer Center also offers a certified sex therapist to 
address changes cancer may cause in the patient’s 
relationship with his or her significant other. 
FINANCIAL COORDINATION
The Cancer Center provides financial coordinators to 
assist patients in financial matters such as precerti-
fication requirements, health insurance and medical 
bills. Financial coordinators also connect patients with 
support agencies to assist them in receiving free or 
reduced-cost services and medical supplies. 
GENETIC COUNSELING
Three board-certified genetic counselors and a medical 
oncologist are available to meet with patients and 
families to discuss benefits of genetic testing and 
perform a personalized risk assessment. The genetic 
counselors provide in-depth reviews of results, counsel 
patients and family members on implications, and 
provide comprehensive surveillance and treatment 
recommendations.
INTERPRETER SERVICES
The health network offers language and sign language 
interpreter services, as well as assistance for people who 
are hearing-impaired. Trained medical interpreters for 
non-English speaking patients and people who com-
municate through sign language are available 24 hours a 
day, seven days a week via live interpreters or a telephon-
ic language interpretation service. 
MARY ROSE MUHR SLEMMER 
SURVIVORPLACE: PROGRAMS FOR LIVING 
AFTER THE CANCER EXPERIENCE
SurvivorPLACE is designed to help people who have 
undergone treatment for cancer to live a healthy life. 
This includes preventing, detecting and treating 
complications from cancer treatment. The care team 
includes a nurse practitioner, registered nurse, social 
worker, registered dietitian and rehabilitation therapist, 
all of whom are specially educated and/or certified in 
oncology. All patients receive a personalized cancer 
survivor summary, which includes information on their 
cancer treatment as well as their survivor care plan.
NURSE NAVIGATORS
Cancer Support Services nurse navigators offer patients 
emotional support, help them communicate with their 
physicians and provide guidance for decision-making 
about choices in their care. Navigators direct patients to 
support services and community resources to assist them 
with treatment-related supplies, financial concerns and 
transportation. They coordinate all members of the 
patient’s health care team and guide the patients to 
survivorship services when their treatment is complete.
NUTRITION COUNSELING
Three registered dietitians are available to meet with 
patients and families to assess nutritional needs and 
determine appropriate nutritional goals and strategies 
during cancer treatment. In fiscal year 2012, our 
dietitians consulted with 2,158 patients. 
PATIENT EDUCATION LIBRARY
The Cancer Center houses the virtual Patient Education 
Library, providing patients with access to current 
cancer-related literature at no charge. Access to the 
library and education can occur on a self-referral basis. 
The health network’s Cancer Center also offers one-to-
one education with an oncology clinical nurse specialist. 
Additional educational materials are also available via 
the 402-CARE phone line.
PREOPERATIVE CLASSES
A preoperative breast class is offered weekly to all newly 
diagnosed breast cancer patients to prepare them for 
surgery and to review post-surgical care, including 
rehabilitation needs. The class is also available in 
 Spanish.
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SUPPORT GROUPS
Support groups offered by the Cancer Center include a 
monthly Men Facing Cancer Discussion Group, 
Metastatic Breast Cancer Support Group, and our 
Breast Cancer Support of Survivor group. In addition to 
providing space for the monthly meetings, Cancer 
Center staff has served to provide educational support 
for the groups as well. Members of the Cancer Support 
team facilitate the support groups. 
The Breast Cancer Support of Survivors (SOS) Program 
offers a 24-hour helpline for newly diagnosed patients. 
Helpline volunteers receive more than 40 hours of 
training, which is conducted by our Cancer Center 
professional staff. Monthly meetings are facilitated by 
the health network’s Cancer Support Services staff and 
provide the volunteers with ongoing education and 
opportunity to seek guidance on dealing with particu-
larly challenging calls. A greeter program provides 
support to both patient and family on the day of breast 
cancer surgery. 
Circulo de Apoyo (Circle of Caring) is held monthly at 
Lehigh Valley Hospital–17th Street. This is designed, 
specifically, for our Hispanic cancer patients and their 
significant others.
OTHER ON-SITE SUPPORT SERVICES
The Cancer Center coordinates closely with other  
health network services. These services include Center 
for Pain Management, Home Care, Hospice, Oncology 
Rehabilitation, palliative care through the OACIS 
(Optimizing Advanced Complex Illness Supports) Team, 




In fiscal year 2012, Lehigh Valley Health Network 
launched an advertising campaign designed to support 
the National Community Cancer Centers Program 
(NCCCP). The goals were to increase opportunities for 
interaction between the Hispanic community and staff 
of the NCCCP at Lehigh Valley Hospital–17th Street, 
and increase access to cancer research protocols. The 
strategy was to create foundational materials to support 
the NCCCP program, starting with a message focused 
on overall healthy living, including diet, activity, regular 
screenings and checkups, and tie these messages to 
cancer prevention. A total of seven events were held in 
fiscal year 2012; 320 people attended. Screenings for 
cancer totaled 153.
CANCER RESOURCE FOR SCHOOLS
The Cancer Center clinical nurse specialists provide 
 lectures on cancer-related topics to health classes in  
area school districts and also to various colleges. The 
topics for fiscal year 2012 included: overview of chemo-
therapy, care of the oncology patient, general oncology 
overview, biotherapy overview and health career pro-
grams. They conducted a total of six lectures.
COMMUNITY CANCER RESOURCES
The Cancer Center also provides lectures on cancer-
related topics as requested by both the lay and profes-
sional communities. The topics for fiscal year 2012 
included nutrition education, breast cancer survivor 
event, prostate cancer prevention and early detection, 
breast health awareness, lung health, prevention and 
early detection of colon cancer, and training for support 
of survivors volunteers and lectures on various breast 
health topics. 
COMMUNITY HEALTH FAIRS
Community outreach is provided in the form of edu-
cation at community health fairs and community 
lectures. The health network’s Cancer Center colleagues 
participated in a total of 22 health fairs in fiscal year 
2011, reaching more than 12,000 people. 
FLU IMMUNIZATION
A total of 168 flu immunizations were provided to 
patients under treatment in the infusion areas at  
Lehigh Valley Hospital–Cedar Crest and Lehigh  
Valley Hospital–Muhlenberg. 
PROSTATE CANCER SCREENING
Free prostate cancer examinations were provided during 
the annual prostate cancer-screening program for men. 
This program is held in collaboration with Lehigh 
Valley Urology Specialty Care, Allentown Health 
Bureau and our Lehigh Valley Hospital–17th Street’s 
Community Health and Wellness Center. Three staff 
urologists as well as five nursing/clerical staff volun-
teered for the screening session. A total of 32 men  
were screened.
SKIN CANCER SCREENING
Free examinations are provided during the annual skin 
screening. Seven dermatologists and 25 nursing/clerical 
staff volunteered for the skin screening held in fiscal 
year 2012. A total of 138 community members were 
screened. This program is conducted in conjunction 
with the American Academy of Dermatology and the 
health network’s division of dermatology. 
BREAST CANCER SCREENING AND CERVICAL 
CANCER SCREENING
Working in collaboration with the Allentown Health 
Bureau, the health network’s Breast Health Services 
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provided free clinical breast exams and screening mammo-
grams for 800 women. In addition, 623 women received 
a free Pap test through our Center for Women’s Medi-
cine and the Community Health and Wellness Center.
LEHIGH VALLEY HEALTH 
NETWORK CANCER CENTER: 
A LINK AMONG COMMUNITY 
RESOURCES
The Lehigh Valley Health Network Cancer Center 
collaborates with many community groups and resources. 
These links are very valuable to our community and our 
patients. Here are five primary partnerships. 
AMERICAN CANCER SOCIETY
Lehigh Valley Health Network frequently connects 
patients with the American Cancer Society. Fifty to 75 
patients a month are referred for information, day-to-
day help and emotional support. The Society provides 
transportation and linkage to other area resources. The 
health network frequently hosts the Society’s Look Good, 
Feel Better workshops where women undergoing treat-
ment learn how to understand and care for changes in 
skin and hair that may occur during treatment. Call the 
Society at 1-800-227-2345 or visit cancer.org.
CANCER SUPPORT COMMUNITY OF THE 
GREATER LEHIGH VALLEY
Multiple patient and family lectures were provided at 
the Cancer Support Community of the Greater Lehigh 
Valley by our physicians and nurses as well as at other 
community-based programs on topics including: 
lymphoma, lung cancer, breast cancer, colon cancer, 
clinical trials and cancer fatigue. Some of these programs 
also were offered on-site at Lehigh Valley Hospital and 
conducted by members of our professional staff. For 
more information on the Cancer Support Community 
of the Greater Lehigh Valley education programs, call 
610-861-7555 or visit cancersupportglv.org.
COMMUNITY EXCHANGE TIMEBANKING
The health network’s Cancer Center collaborates with 
the Lehigh Valley Health Network Community Exchange 
TimeBank. Frequently referred to as Community 
Exchange, this program provides assistance to patients 
in need and creates a vibrant community working 
together. Community Exchange is a network of people 
who both volunteer and earn time through a model for 
community action and connectivity. 
LEHIGH COALITION FOR CANCER CONTROL
Since 1987, the health network’s Cancer Center has 
worked along with the Allentown Health Bureau,  
St. Luke’s University Hospital and Sacred Heart 
 Hospital as the Lehigh Coalition for Cancer Control. 
The goal of the Coalition is to remove barriers that may 
prevent women from getting a mammogram and/or Pap 
test. These barriers include cost, lack of insurance 
coverage and lack of a medical provider. Together, we 
help uninsured and underinsured women follow the 
breast and cervical cancer screening recommendations. 
For more information, call 610-437-7513.
LEUKEMIA AND LYMPHOMA SOCIETY
We partner with the Leukemia and Lymphoma Society 
(LLS) to offer patient education programs as well as the 
Cirulo de Apoyo support group for our Latino patients 
and their families. We collaborated in April 2012 to 
offer activities for Minority Cancer Awareness Week at 
our Community Health and Wellness Center. The LLS 
provides us with education materials for all patients with 
blood cancers. They also offer a wide range of webinars 
for both professionals and patients. For more infor-
mation, call 610-266-8513 or visit them at www.lls.org.
RESEARCH AT LEHIGH VALLEY HEALTH 
NETWORK’S CANCER CENTER
Clinical research in oncology has been conducted at 
Lehigh Valley Health Network for more than 35 years, 
initially with the National Surgical Adjuvant Breast and 
Bowel Project (NSABP) and the Eastern Cooperative 
Oncology Group (ECOG). During the last 15 years, the 
health network has remained members with NSABP, 
ECOG and expanded to include cancer prevention trials 
in breast and prostate cancer, treatment trials in surgical 
oncology (ACOSOG), Gynecologic Oncology (GOG), 
the North Central Cancer Treatment Group (NCCTG), 
and we are a member of the Clinical Trials Support Unit 
(CTSU). The health network’s cancer program enjoys a 
collaborative relationship with Moffitt Cancer Center 
and recently The Wistar Institute of Anatomy and 
Biology, both of which are NCI-designated Cancer 
 Centers. The health network’s Cancer Center also 
participates in local, national and pharmaceutical 
studies designed to prevent and treat cancers. 
The Cancer Program’s Protocol Priority Review Com-
mittee (PPR) meets monthly to review its clinical trial 
portfolio. The committee’s goal is to keep the oncology 
clinical trial portfolio scientifically sound and appro-
priate for the resources of the Cancer Program and the 
Oncology Clinical Trials Office. Research at the health 
network is supported by a central research office, the 
Network Office of Research and Innovation (NORI), 
comprised of the Office of Clinical Operations, the 
Office of Integrity and Education, the Office of 
 Research and Finance and the Human Subject 
 Protection Office.
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CANCER COMMITTEE MEMBERSHIP
At Lehigh Valley Health Network, we excel in care for our cancer patients. Lehigh Valley Health Network’s Cancer Committee 
oversees activities of the cancer program and is responsible for ensuring quality care and facilitating advancements. The 
multidisciplinary cancer committee is composed of medical and administrative personnel with a full range of specialty skill 
sets. We also work closely with the American Cancer Society and Leukemia and Lymphoma Society.  
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2011 CANCER COMMITTEE MEMBERSHIP
MEMBER NAME DISCIPLINE
Andrews, Charles MD Chair, Radiation Oncologist
Baccala, Angelo Jr. MD Surgeon Urology
Barnaby, Janine RPh, BS, BCOP Oncology-certified Pharmacist
Barraco, Debra BS Tumor Registry Research Associate
Boulay, Richard MD Chair, Cancer Committee; Chair, Gynecology Oncology
Boyle, Linda PT, DPT, OCS, CLT-LANA Rehabilitative Services
Brennan, Jennifer RD, CSO, LDN Registered Dietitian
Brong, Diane LCSW Social Worker and Psychosocial Services Coordinator
Chung, Heiwon MD General Surgeon
Dellers, Elizabeth MD Anatomic and Clinical Pathology
Dwinal, Brenda CTR Supervisor, Tumor Registry
Earley, Nancy MS, RT(R)(T) Cancer Program Administrator
Fillebrown, Ruth RN, CHPN Palliative Care Team Member, Hospice RN Education Coordinator
Friedman, Eliot  MD Chief, Division of Hematology-Medical Oncology
Gheller, April BSN, MS, OCN Quality Coordinator/Nurse, Infusion Area
Harper, Gregory MD, PhD Hematology-Medical Oncology, NCCCP Medical Director
Kimmel, Sharon PhD, MHA, CCRP Director, Oncology Clinical Trials and Data Management
Mack, Nadesda RN, BSN, MBA, OCN Cancer Program Administrator
McGonigle, Lenore MEd Facility-Based Education/Community Outreach
Monteleone, Philip MD Pediatric Oncologist
Namey, Tara MS, CGC Genetic Counselor, Cancer Risk and Assessment Program
O’Connell, Mary Ellen MSN, MBA Performance Improvement and Quality Management (Network)
Park, John MD Surgeon, Colon and Rectal
Ray, Daniel MD Director, OACIS Palliative Care
Reimer, Nicole BSN, OCN Director, Oncology Medical Surgery Inpatient Unit
Rienzo, Robert MD Chief, Section of Nuclear Medicine
Rivera, Ada BA Director, NCCCP Quality and Data Management
Schiavone, Karen (non-voting) American Cancer Society Representative
Sevedge, Kathleen RN, MA, AOCN Director, Cancer Support Services
Skandan, Savitri MD Hematology-Medical Oncology, CoC Cancer Liaison Physician
Steigerwalt, Susan RT (R) (M) Director, Breast Health Services 
Weinhold, Keith MHA, FACHE Senior Vice President, Operations
Whitney, Samiyyah RN, BSN Supervisor, Oncology Clinical Research,  Network Office of Research
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